Mr Ronan Ryan from St James's Hospital gives a though provoking and excellent overview of surgery in #NSCLC

Minimally invasive surgery and RATS now established as SOC

📢 national imperative for centralisation
IASLC #AILCC24

Kicking Saturday morning off at #AILCC24 Patrick Forde gives a masterful overview of peri-operative #immunotherapy in NSCLC

➡️ pCR highly predictive of outcome
➡️ liver might be a sanctuary site for relapse
➡️ clear need to optimise treatment duration
IASLC

#AILCC24

Starting day 2 with Patrick Forde on periop chemoIO in nsclc. Compared to his talk 2 yrs ago, major advances include:

- periop trials now show OS benefit (KN671)
- pCR an emerging surrogate endpt
- ICER/financial evaluations are key

IASLC #IrishLungCancerAlliance #LCSM

Career advice from the dynamic duo Drs. Dr. Julie Brahmer & Natasha Leighl
#lcsm

Comprehensive roundup of where ctDNA fits into lung cancer guidelines right now from Prof Natasha Leighl at the All-Ireland Lung Cancer Conference

Value is clear for upfront testing alongside tissue...

Next stops... Maybe MRD after surgery? Teatment monitoring during XRT?

Great overview on liquid biopsy from Prof Natasha Leighl from University Health Network at #AILCC24

Makes the argument for liquid biopsy up front or a concurrent approach.

#IrishLungCancerAlliance IASLC

#AILCC24 Super kickoff of the meeting from Dr Daniel Ryan on Lung Cancer Screening, highlighting key issues to address:

- uptake
- balancing benefit & harm
- expansion to a ‘lung health check’ to ⬇️stigma & ⬆️overall health

⁦Beaumont RCSI Cancer Centre⁩ ⁦IASLC⁩ #LCSM

Dr Emmet O’Brien gives #AILCC24
a comprehensive overview on the negative health impacts of #smoking

➡️ estimated that a container of cigarettes causes 10 deaths

🚨Urgent need to denicontinise vapes and raise the legal smoking age to 21

#AILCC24 #IrishLungCancerAlliance IASLC #LCsM

Pre 2024 Ireland Lung Cancer Conference exercise program with Drs. Dr. Julie Brahmer & Jarushka Naidoo ! #AILCC24 #lcsm 🇮🇪

Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…

Wonderful to see our #liquidbiopsies research highlighted in the #AACR24 #precisiononcology special series!

Read the open access Clinical Cancer Research study: aacrjournals.org/clincancerres/…

AACR Johns Hopkins Thoracic Oncology Johns Hopkins Medicine Lavanya Sivapalan Joseph Murray

The Molecular OncologyLab is on the way to #AACR24 ! Hope to see everyone at our presentations & poster sessions covering #liquidbiopsies #cancergenomics , #Immunotherapy #PrecisionOncology ! + celebrating 3⃣ scholar-in-training awards! AACR Blair Landon Lavanya Sivapalan Maria Fatteh

Lung cancer in never-smokers represent the 5thleading cause of cancer-related mortality in the world. They are highly enriched for targetable oncogenic alterations, have low TMB, low rates of PD-L1 positivity, & lack mutational signatures. They occur almost exclusively as…

We are absolutely delighted with this appointment and are very looking forward to the years ahead! Congratulations Gerry Hanna ! #SLRON RadiationTherapyTCD Trinity St James's Cancer Institute Irish Cancer Society Dublin Midlands Hospital Group NCCP

Most viewed in the last 7 days from JAMA Oncology:

Do patients with resectable NSCLC and tumor programmed cell death 1 ligand 1 levels less than 1% benefit from neoadjuvant chemoimmunotherapy?

ja.ma/3TELLl3

At the risk of stirring up trouble with my #RadOnc friends, let's talk about PACIFIC 2, presented by Jeff Bradley, MD at #ELCC24 . To me it disappoints and dispels some mythology about CRT for stage III patients. I would love to hear everyone's thoughts.

🚀 Excited to announce our latest Cell publication on 'Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.'
An important collaboration shedding light on promising avenues in cancer research.📑✨
sciencedirect.com/science/articl…

Calling all medical students in their 4th or 5th year 📢 Dive into the world of #medicaloncology with our ESMO Courses on #MedicalOncology tailored just for you. All application info 👉 ow.ly/cwTX50R3b1e
#ESMOStudents Andres Cervantes Matteo Lambertini, MD PhD Jon Lim

Very interesting! METIS p3 trial - TTF median time to intracranial progression of 21.9 months compared to 11.3 months in pts treated with supportive care for brain Mets from lung cancer after stereotactic radiation (n=298; hazard ratio=0.67; P=0.016) #lcsm reuters.com/business/healt…

#AILCC24
All Ireland Lung Cancer Conference
📅12-13 April 2024
📍Johnstown Estate

Join us for 2 days of all things thoracic oncology, featuring international & national leaders

Registration open!
In-person: forms.gle/6JkfpPMkCiP3H2…
Virtual: forms.gle/MfmUGyHQH5LrRt…

IASLC #LCSM